Instalab
logoInstalab

Glucose

Blood Test
A routine serum check that can catch silent blood-sugar drift before diabetes declares itself.
4.8 (2,647 reviews)
Tested by Quest, Access Medical or Boston Heart
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers · 8-hour fast required
Get results
Explained with clear next steps, no medical jargon

Should you take a Glucose test?

This test is most useful if any of these apply to you.

Healthy but Staying Ahead
Blood sugar can drift for years before symptoms. A baseline lets you spot the trend early.
Diabetes Runs in Your Family
Family history raises diabetes risk. Testing shows whether your own fasting glucose is starting to drift.
Carrying Extra Weight or High Blood Pressure
These often travel with insulin resistance, and glucose can show when risk is becoming visible.
Told Your Blood Sugar Is Borderline
A borderline result deserves a repeat and a trend, so you can see whether changes are working.

About Glucose

Fasting serum glucose is the most common way your metabolism gets checked, and the single number does two jobs at once. It tells you how your body is handling sugar right now, and it flags whether you're sliding toward diabetes long before you'd feel anything. The second job matters more.

The catch is that this familiar number is quietly fragile. Blood left sitting in the tube keeps burning sugar, so a delayed sample can read several to nearly twenty points lower than the truth, and that gap matters most right at the line where a diagnosis is made.

What the Number Actually Measures

Glucose is a small sugar molecule, the main free fuel circulating in your blood. On this test, the lab measures glucose in serum. Serum is the liquid left after a blood sample clots.

Many diabetes studies and diagnostic rules use venous plasma glucose instead. Promptly handled serum and plasma are usually close, but delayed serum can read low because blood cells keep using glucose after the draw.

When you are not eating, your liver is the main source, releasing glucose from its stores and building more under the push of stress hormones like cortisol and adrenaline.

So a reading is a running balance: how much your liver puts out, how much your muscles and other tissues pull in, and how well insulin is doing its job. That is why the same number can mean different things in different people. It reflects the whole system, not one gland.

A Snapshot, Not a History

Serum glucose captures this moment. Its main companion, glycated hemoglobin (HbA1c), reflects your average sugar exposure over the past two to three months. They answer different questions, and neither replaces the other. A fasting glucose can look fine on a day when your longer-term average has already crept up, and the reverse can happen too.

Diabetes and the Prediabetes Window

The classic use is spotting diabetes, but the number climbs gradually for years first. That slow rise is the window worth catching, because once abnormal glucose handling is found, lifestyle change lowers the odds of it becoming diabetes.

Fasting glucose rules in better than it rules out. Measured against the oral glucose tolerance test, which usually uses venous plasma after you drink a sugar load, the standard fasting threshold caught only about half of diabetes cases while correctly clearing nearly everyone without the disease. A normal fasting number is reassuring, but it is not a clean bill of health.

High Glucose During a Serious Illness

When glucose runs high at the moment of an acute illness, the course tends to be rougher. This holds across very different situations, and often in people who were never known to have diabetes.

Who Was StudiedWhat Was ComparedWhat They Found
Adults hospitalized with pneumoniaHigh vs normal glucose on admissionAbout two and a half times the risk of dying in the near term
Adults having a major heart attackHigh vs normal glucose on admissionAbout three times the risk of dying in the hospital
Adults hospitalized with COVID-19 and no known diabetesFasting glucose in the diabetic range vs lowerMore than double the risk of dying within 28 days

Sources: Yuan et al. 2024 (pneumonia); Alkatiri et al. 2024 (heart attack); Wang et al. 2020 (COVID-19).

What this means for you: a high glucose drawn while you are seriously ill is partly a stress signal, not only a sign of diabetes. It still marks a harder course, which is one reason a value taken during illness should be rechecked once you have recovered rather than treated as your baseline.

Stroke and Pancreatitis

The same pattern shows up elsewhere. After a clot was removed from a blocked brain artery, people with high admission glucose had worse recovery, with death in 40 out of 100 versus 23, and more bleeding into the brain, 9 versus 5. In acute pancreatitis, high glucose on admission tracked with more inflammation. Peak glucose during the hospital stay tracked with longer stays, roughly nine and a half days versus six and a half.

One Finding That Looks Backwards

In several intensive-care studies, high glucose predicted death in people without diabetes but not in those who already had it, and in sepsis the risk was U-shaped, with both low and very high values faring worse than a middle band. This is not a contradiction. Glucose is acting as a stress gauge rather than a fixed good-or-bad number: a spike in someone whose body normally runs steady signals a bigger physiological hit than the same spike in someone whose system is used to running high. The value only makes sense read against the person's usual metabolism.

Pregnancy

In pregnancy the risk is continuous, without a clean threshold. In one fasting serum study, higher glucose was linked to about twice the odds of gestational diabetes. Larger pregnancy studies using venous plasma during a tolerance test found the same continuous pattern: even values below diabetic thresholds tracked with larger babies.

Once gestational diabetes is found and treated, rates of cesarean delivery, oversized babies, and newborn intensive-care admission drop, so fasting glucose serves as a useful screen here even though the tolerance test confirms the diagnosis. A post-load reading, especially the one-hour value, detects considerably more dysglycemia in pregnancy, so the two are not interchangeable.

Why One Reading Is Not Enough

A single fasting glucose carries real biological noise. In healthy adults, a change of up to about 15 percent between two readings can be normal variation rather than a true shift. So one value is a dot, and the trend is the signal.

Watching the direction over time tells you what a single number cannot: whether you are drifting up, holding steady, or actually responding to a change you made. Get a baseline, recheck in three to six months if you are changing your diet, activity, or weight, and at least once a year after that. If you have risk factors, know this number sooner rather than later.

What to Do With an Out-of-Pattern Result

A single high fasting glucose is a prompt, not a verdict. Repeat it, and pair it with HbA1c. If the two disagree or sit near the line, an oral glucose tolerance test, sometimes with a one-hour reading, gives a clearer answer because fasting glucose alone misses a lot of after-meal disease.

Adding fasting insulin, or the HOMA-IR calculation that combines glucose and insulin, shows whether insulin resistance is driving the number. Persistent or borderline results are worth reviewing with a clinician, and an endocrinologist if the picture is unusual, such as very young onset, rapid weight loss, or an autoimmune slant.

What Can Fool a Single Reading

  • Sample sitting too long: blood keeps consuming glucose after the draw, so a delayed or slowly separated sample can read several to nearly twenty points low. A promptly spun sample avoids this.
  • What it's measured in: serum and plasma are usually close when handled promptly, but whole blood runs lower. Fingerstick and venous numbers can also diverge after meals. Don't compare them as if they were the same specimen.
  • A recent meal or hard workout: eating raises glucose for hours, and a single intense session can briefly nudge it down and then rebound. Neither reflects your steady state, which is why the test is done fasting.
  • Normal day-to-day variation: small shifts between two readings often fall inside the expected biological swing rather than signaling real change.

What Moves This Biomarker

Evidence-backed interventions that affect your Glucose level

Decrease
GLP-1 receptor agonist therapy, such as semaglutide
These drugs lower fasting and after-meal glucose and, in type 2 diabetes, have randomized-trial evidence for heart and kidney benefits. On their own they have a low severe low-blood-sugar risk, but that risk rises if they are paired with insulin or sulfonylureas.
MedicationStrong Evidence
Decrease
Insulin therapy for type 1 diabetes or severe hyperglycemia
Insulin directly lowers blood glucose by moving glucose into tissues and turning down liver glucose output. It is essential in type 1 diabetes and used in type 2 diabetes when glucose is very high, symptoms are present, or other therapies are not enough.
MedicationStrong Evidence
Increase
Glucocorticoid steroid treatment such as prednisone
Steroids are the best-documented common cause of unintended high glucose, and the effect is real dysglycemia, not a testing quirk. In people without diabetes, about a third developed hyperglycemia and roughly one in five developed diabetes on steroid therapy, and high-dose inpatient use pushed more than half into hyperglycemia.
MedicationStrong Evidence
Decrease
Sustained diet, activity, and weight-loss changes in people with prediabetes
This has the strongest evidence for keeping fasting glucose from climbing. In adults with prediabetes who were overweight, sustained lifestyle change lowered the rate of progressing to diabetes and improved fasting glucose in the systematic review behind US screening guidelines.
LifestyleModerate Evidence
Decrease
Metformin for type 2 diabetes and selected high-risk prediabetes
Metformin lowers glucose mainly by turning down liver glucose release. It prevents or delays diabetes in selected high-risk adults with prediabetes and remains a common foundation drug in type 2 diabetes, though treatment choice now depends on heart, kidney, weight, and hypoglycemia risk too.
MedicationModerate Evidence
Increase
Statin therapy for cholesterol
Statins nudge fasting glucose up slightly and modestly raise the chance of developing diabetes, a real metabolic effect rather than a lab artifact. The rise is small and the cardiovascular benefit of statins is far larger, so this is a reason to keep an eye on glucose, not to stop the drug. Pravastatin and pitavastatin appear more glucose-neutral than others.
MedicationModest Evidence

Frequently Asked Questions

Panels containing Glucose

Glucose is included in these pre-built panels.

References

45 studies
  1. B. Darwin, Eka Yuniar, Endang Endang, I. KurniawanJournal of Applied Medical and Biological Sciences2020
  2. Akihiro Yoshida, T. Nagasawa, Madoka Inoue, Suguru Hiramoto, F. Murakami, K. Tsunekawa, Takao KimuraNutrients2026
  3. J. Kang, Cheol-young Park, S. Ihm, S. W. ParkDiabetes & Metabolism Journal2016